-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Outperform on Twist Bioscience, Lowers Price Target to $135

Benzinga·11/13/2026 12:38:05
Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $187 to $135.